Loading: 100%
Novocure Ltd logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 460 (as per Q4 2016)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker NVCRno data available
Financial year endsFY ends End of no data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1706121824
datesClosing price (adj.)
13.10.201716.30
11.10.201718.30
04.10.201720.00
27.09.201721.20
20.09.201721.15
13.09.201721.75
06.09.201719.40
30.08.201720.25
23.08.201719.25
16.08.201720.00
09.08.201720.05
02.08.201718.85
26.07.201719.25
19.07.201718.35
12.07.201719.90
05.07.201718.15
27.06.201716.85
20.06.201715.95
13.06.201715.10
06.06.201713.50
30.05.201712.50
23.05.201711.60
16.05.201712.00
09.05.201712.15
02.05.201711.85
25.04.201710.80
18.04.201710.80
11.04.201711.00
04.04.201710.05
28.03.20178.00
21.03.20177.00
14.03.20177.00
07.03.20177.30
28.02.20177.60
21.02.20177.30
14.02.20177.45
07.02.20176.80
31.01.20176.35
24.01.20176.35
17.01.20176.60
10.01.20178.15
03.01.20177.85
27.12.20168.10
19.12.20168.80
12.12.20168.95
05.12.20168.30
28.11.20168.35
21.11.20169.75
14.11.20169.00
07.11.20167.25
31.10.20166.05
24.10.20166.93
17.10.20167.32
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
16.30n/a
Market Capitalisation
in million USD
1,437n/a
Enterprise Value
in million USD
1,344n/a
Common Shares Outstanding
as per Apr 20, 2017
88,149,928n/a
Preferred Shares Outstanding
as per Apr 20, 2017
62,744,517n/a
Average Basic Shares Outstanding
TTM
86,322,403n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 189n/a
Receivables 12n/a
Total Current Assets 243n/a
PP&E 9n/a
Total Assets 255n/a
Accounts Payable 15n/a
Current Debt 0n/a
Total Current Liabilities 32n/a
Long-Term Debt 96n/a
Total Liabilities 136n/a
Total Equity 129n/a
Cash Flow
Depreciation & Amortisation 6n/a
Change in Working Capital -18n/a
Operating Cash Flow -104n/a
Net Change in PP&E and Intangibles -6n/a
Investing Cash Flow -3n/a
Dividends Paid 0n/a
Financing Cash Flow 75n/a
Total Change in Cash -31n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.09n/a
Other Ratios
Current Ratio 762.8%n/a
Liabilities to Equity Ratio 105.3%n/a
Debt to Assets Ratio 37.9%n/a
Profit & Loss StatementP&L data quality: 77% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Revenue
10
15
33
89
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-7
-10
-21
-40
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
3
5
12
49
Other Operating Income
0
0
0
0
Operating Expenses
-68
-86
-116
-152
Selling, General & Administrative
-33
-45
-73
-110
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
-35
-40
-44
-41
Depreciation & Amortization
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
-64
-80
-104
-102
Non-Operating Income (Loss)
-13
0
-3
-6
Interest Expense, net
-13
0
-3
-6
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
Pretax Income (Loss), Adjusted
-77
-80
-107
-109
Abnormal Gains (Losses)
0
0
0
0
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
-77
-80
-107
-109
Income Tax (Expense) Benefit, net
0
0
-4
-10
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
-77
-81
-112
-119
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
-77
-81
-112
-119
Minority Interest
0
0
0
0
Net Income
-77
-81
-112
-119
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
-77
-81
-112
-119
Remarks
restated on Mar 1, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Apr 27, 2017 n/a
calculated values,
Balance SheetBS data quality: 50% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
103
269
220
Cash & Cash Equivalents
n/a
58
119
100
Short Term Investments
n/a
45
150
120
Accounts & Notes Receivable
n/a
0
0
6
Accounts Receivable, Net
n/a
0
0
6
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
3
14
26
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
6
11
10
Prepaid Expenses
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
6
11
10
Total Current Assets
n/a
112
294
262
Property, Plant & Equipment, Net
n/a
2
6
9
Property, Plant & Equipment
n/a
2
6
9
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
0
1
2
Intangible Assets
n/a
0
0
0
Goodwill
n/a
0
0
0
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
0
1
2
Total Noncurrent Assets
n/a
2
7
10
Total Assets
n/a
114
301
272
Liabilities and owners' equity
Payables & Accruals
n/a
18 17669000
29 28627000
37 36882000
Accounts Payable
n/a
10 10033000
17 16755000
18 18356000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
8 7636000
12 11872000
19 18526000
Short Term Debt
n/a
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
Total Current Liabilities
n/a
18 17669000
29 28627000
37 36882000
Long Term Debt
n/a
0 0
23 23097000
96 96231000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2 2332000
5 4792000
7 6623000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2 2332000
5 4792000
7 6623000
Total Noncurrent Liabilities
n/a
2 2332000
28 27889000
103 102854000
Total Liabilities
n/a
20 20001000
57 56516000
140 139736000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
374 374375000
640 640406000
664 664154000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-277 -276500000
-388 -388081000
-520 -519926000
Other Equity
n/a
0 0
-2 -1505000
-2 -1883000
Equity Before Minority Interest
n/a
98 97875000
251 250820000
142 142345000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
98 97875000
251 250820000
142 142345000
Total Liabilities & Equity
n/a
118 117876000
307 307336000
282 282081000
Remarks restated on n/a restated on Mar 1, 2016 n/a restated on Feb 23, 2017 n/a restated on Apr 27, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Net Income/Starting Line
-77
-81
-112
-132
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
1
2
3
6
Non-Cash Items
13
3
8
28
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
10
1
1
-10
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
-53
-74
-100
-108
Change in Fixed Assets & Intangibles
-2
-1
-5
-6
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
13
-45
-111
18
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
10
-46
-115
13
Dividends Paid
0
0
0
0
Cash From (Repayment of) Debt
-9
0
23
73
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
192
2
254
2
Increase in Capital Stock
192
2
254
2
Decrease in Capital Stock
0
0
0
0
Other Financing Activities
0
0
0
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
183
2
277
75
Net Cash Before Disc. Operations and FX
141
-118
62
-20
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
141
-118
62
-20
Effect of Foreign Exchange Rates
0
0
0
0
Net Changes in Cash
141
-118
62
-20
Remarks
restated on Mar 1, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Apr 27, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo